Shock resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{Sepsis}} {{CMG}}; {{AE}} {{AZ}} ==Definition== ==Causes== ===Life Threatening Causes=== ===Common Causes=== ===Prognosis=== ==Management== ==Do's== ==Do..." |
Ahmed Zaghw (talk | contribs) |
||
| Line 16: | Line 16: | ||
==Management== | ==Management== | ||
{{Family tree/start}} | |||
{{Family tree | | | | | | | | A01 | | | |boxstyle_A01=BACKGROUND:SALMON|A01= '''Shock'''}} | |||
{{Family tree | | | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | | | B01 | | | |B01= '''ABCD''' <br> Airway / O2 / 2 wide bore IV access / 12-lead ECG / focused H&P / CXR }} | |||
{{Family tree | | | | |,|-|-|-|+|-|-|-|.| | }} | |||
{{Family tree | | | | C01 | | C02 | | C03 |C01='''Volume defect'''|C02= '''Pump defect'''|C03= '''Heart Rate''' disturbances }} | |||
{{Family tree | | | | |`|-|v|-|'| | | |!| }} | |||
{{Family tree | | | | | | D01 | | | | D02 |D01= '''Fluid/Blood''' products ± '''Vasopressors'''|D02= '''Arrhythmia algorithm'''}} | |||
{{Family tree | | |,|-|-|-|+|-|-|-|.| | }} | |||
{{Family tree | | G01 | | G02 | | G03 |G01= SBP < 70 with cardiogenic shock |G02= SBP 70-100 with cardiogenic shock |G03= SBP 70-100 with no shock }} | |||
{{Family tree | | |!| | | |!| | | |!| | }} | |||
{{Family tree | | H01 | | H02 | | H03 |H01= Norepinephrine 1-30 μg/min |H02= Dopamine 2–20 μg/kg/min |H03= Dobutamine 2–20 μg/kg/min }} | |||
{{Family tree/end}} | |||
==Do's== | ==Do's== | ||
Revision as of 01:55, 3 December 2013
|
Sepsis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Shock resident survival guide On the Web |
|
American Roentgen Ray Society Images of Shock resident survival guide |
|
Risk calculators and risk factors for Shock resident survival guide |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Definition
Causes
Life Threatening Causes
Common Causes
Prognosis
Management
| Shock | |||||||||||||||||||||||||||||
| ABCD Airway / O2 / 2 wide bore IV access / 12-lead ECG / focused H&P / CXR | |||||||||||||||||||||||||||||
| Volume defect | Pump defect | Heart Rate disturbances | |||||||||||||||||||||||||||
| Fluid/Blood products ± Vasopressors | Arrhythmia algorithm | ||||||||||||||||||||||||||||
| SBP < 70 with cardiogenic shock | SBP 70-100 with cardiogenic shock | SBP 70-100 with no shock | |||||||||||||||||||||||||||
| Norepinephrine 1-30 μg/min | Dopamine 2–20 μg/kg/min | Dobutamine 2–20 μg/kg/min | |||||||||||||||||||||||||||